BostonGene
Founded Year
2015Stage
Series B | AliveTotal Raised
$200MValuation
$0000Last Raised
$150M | 3 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-70 points in the past 30 days
About BostonGene
BostonGene is a biotechnology company that provides services including molecular and immune profiling, tumor microenvironment analysis, and next-generation sequencing to assist in treatment options for cancer patients. The company serves the healthcare sector, including patients, providers, and biopharma companies. It was founded in 2015 and is based in Waltham, Massachusetts.
Loading...
BostonGene's Product Videos
BostonGene's Products & Differentiators
Tumor Portrait
Comprehensive whole exome and whole transcriptome profiling with actionable findings, treatment recommendations and available clinical trials in one simple report. Providers may select add on tests including liquid biopsy, IHC, or Tumor Origin Prediction.
Loading...
Research containing BostonGene
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned BostonGene in 1 CB Insights research brief, most recently on Jul 7, 2022.
Expert Collections containing BostonGene
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
BostonGene is included in 4 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,270 items
Digital Health
11,306 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Oncology Tech
463 items
This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.
Digital Health 50
50 items
BostonGene Patents
BostonGene has filed 62 patents.
The 3 most popular patent topics include:
- molecular biology
- oncology
- clusters of differentiation
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/4/2021 | 3/18/2025 | Oncology, Molecular biology, Machine learning, Dermal and subcutaneous growths, Rare cancers | Grant |
Application Date | 12/4/2021 |
|---|---|
Grant Date | 3/18/2025 |
Title | |
Related Topics | Oncology, Molecular biology, Machine learning, Dermal and subcutaneous growths, Rare cancers |
Status | Grant |
Latest BostonGene News
Apr 9, 2025
APR 08, 2025 | 5:08 PM PDT | BIOCENTURY | MANAGEMENT TRACKSAS ROCKET AWAITS FDA REVIEW, J&J VET CHAUDHURI JOINS AS COMMERCIAL LEADBY Plus: C-suite changes at Freenome, Telix, Trex Bio, Myricx, General Oncology, Bostongene and Acrivonhttps://www.biocentury.com/article/655574/as-rocket-awaits-fda-review-j-j-vet-chaudhuri-joins-as-commercial-lead© 2025 BioCentury Inc. All Rights Reserved
BostonGene Frequently Asked Questions (FAQ)
When was BostonGene founded?
BostonGene was founded in 2015.
Where is BostonGene's headquarters?
BostonGene's headquarters is located at University Office Park III, Waltham.
What is BostonGene's latest funding round?
BostonGene's latest funding round is Series B.
How much did BostonGene raise?
BostonGene raised a total of $200M.
Who are the investors of BostonGene?
Investors of BostonGene include NEC, Japan Industrial Partners and Impact Investment Capital.
Who are BostonGene's competitors?
Competitors of BostonGene include Caris Life Sciences and 5 more.
What products does BostonGene offer?
BostonGene's products include Tumor Portrait and 4 more.
Who are BostonGene's customers?
Customers of BostonGene include Takeda and LigaChem.
Loading...
Compare BostonGene to Competitors
Strata Oncology provides precision oncology solutions that integrate molecular profiling and decision support into cancer care. The company offers genomic sequencing services to identify tumor profiles and match patients with therapies and clinical trials. It was founded in 2015 and is based in Ann Arbor, Michigan.
Molecular You provides preventive health assessments and lifestyle coaching within the health sector. The company offers a health report based on blood profile analysis, detailing an individual's current health status and future disease risks. It serves individuals seeking personalized health care and organizations interested in population health management. It was founded in 2014 and is based in Vancouver, Canada.
First Ascent Biomedical focuses on cancer treatment solutions within the biomedical sector. The company provides a platform that combines functional drug testing, genomics, and artificial intelligence to develop treatment plans for cancer patients. Its services are aimed at the healthcare industry, including patients, physicians, and pharmaceutical companies. It was founded in 2018 and is based in Miami, Florida.
SimBioSys is a TechBio company that specializes in precision medicine within the healthcare sector. The company offers diagnostic technology that utilizes artificial intelligence, spatial biophysics, and data science to analyze tumors, with the goal of enhancing clinical decision-making. SimBioSys serves the healthcare industry, particularly in cancer treatment and research. It was founded in 2018 and is based in Chicago, Illinois.
Genomic Expression focuses on RNA analysis for healthcare, operating within the biotechnology and healthcare sectors. The company offers a platform for analyzing RNA to detect diseases and monitor health, targeting cancer treatment. Its services cater to the healthcare industry, including doctors and patients. It was founded in 2009 and is based in New York, New York.
Perthera operates as a healthcare artificial intelligence company that focuses on advancing precision medicine. The company offers an artificial intelligence (AI) enabled platform utilizing patient history and multi-omic testing results to match cancer patients with ranked therapy options and accelerates clinical and therapeutic development. It was formerly known as Personalized Cancer Therapy. It primarily serves the healthcare industry in the oncology sector. It was founded in 2012 and is based in McLean, Virginia.
Loading...